title: Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
abstract: An elevated level of plasma total homocysteine is an independent, graded and strong risk factor for cardiovascular disease, which shows a strong interactive effect with conventional risk factors. It is a predictor of cardiovascular disease events in high-risk populations, but is weakly associated with risk in healthy individuals. A common polymorphism in the MTHFR gene is a major determinant of the total homocysteine level, but is unrelated to cardiovascular disease risk in most studies. This observation is in accordance with the view that high total homocysteine itself may not be particularly deleterious, but provokes vascular occlusion under conditions predisposing to cardiovascular disease.
authors.affiliation: Department of Pharmacology, University of Bergen, Norway. helga.refsum@farm.uib.no
authors.forename: H
authors.initials: H
authors.lastname: Refsum
authors.forename: P M
authors.initials: PM
authors.lastname: Ueland
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood*; D005260:Female; D006710:Homocysteine / Q000097:blood* / Q000652:urine; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D006710:Homocysteine; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)